These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19018732)

  • 41. Epidemiology of chronic kidney disease in central and eastern europe.
    Rutkowski B; Król E
    Blood Purif; 2008; 26(4):381-5. PubMed ID: 18535372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors and screening for chronic kidney disease.
    Vassalotti JA; Fox CH; Becker BN
    Adv Chronic Kidney Dis; 2010 May; 17(3):237-45. PubMed ID: 20439092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CKD screening and management in the Veterans Health Administration: the impact of system organization and an innovative electronic record.
    Patel TG; Pogach LM; Barth RH
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S78-85. PubMed ID: 19231765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions.
    Bakken AM; Protack CD; Saad WE; Hart JP; Rhodes JM; Waldman DL; Davies MG
    Ann Vasc Surg; 2009; 23(5):560-8. PubMed ID: 19128934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic kidney disease has a more powerful impact on peripheral arterial disease than metabolic syndrome in Japanese type 2 diabetic patients.
    Tsunoda K; Shimajiri Y; Morita S; Furuta M; Kadoya Y; Yamada S; Nanjo K; Sanke T
    Metab Syndr Relat Disord; 2009 Aug; 7(4):323-6. PubMed ID: 19558271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The epidemiology and control of anaemia among pre-ESRD patients with chronic kidney disease.
    McClellan WM; Jurkovitz C; Abramson J
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():58-65. PubMed ID: 16281960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of late-stage CKD and aging on medical utilization in the elderly population: a closed-cohort study in Taiwan.
    Lin MY; Hwang SJ; Mau LW; Chen HC; Hwang SC; Wu LC; Chiu HC
    Nephrol Dial Transplant; 2010 Oct; 25(10):3230-5. PubMed ID: 20335272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology and risk factors for chronic kidney disease.
    McClellan WM
    Med Clin North Am; 2005 May; 89(3):419-45. PubMed ID: 15755460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The epidemic challenge of chronic kidney disease in older patients.
    Abdelhafiz AH; Tan E; El Nahas M
    Postgrad Med; 2008 Nov; 120(4):87-94. PubMed ID: 19020370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic kidney disease (CKD) in the elderly -- a geriatrician's perspective.
    Munikrishnappa D
    Aging Male; 2007 Sep; 10(3):113-37. PubMed ID: 17701657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
    Collins AJ; Vassalotti JA; Wang C; Li S; Gilbertson DT; Liu J; Foley RN; Chen SC; Arneson TJ
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S71-7. PubMed ID: 19231764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Is chronic kidney disease (CKD) a problem of great epidemiological relevance?].
    Lozano L; Sánchez R; Navarro J; Alcázar R
    Nefrologia; 2008; 28 Suppl 5():99-103. PubMed ID: 18847428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
    Kendrick J; Chonchol MB
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities.
    Khan S
    Nephron Clin Pract; 2007; 105(4):c159-64. PubMed ID: 17259740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The chronic kidney disease epidemic: stepping back and looking forward.
    Kiberd B
    J Am Soc Nephrol; 2006 Nov; 17(11):2967-73. PubMed ID: 17035615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
    Iseki K
    J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is there a need for early detection programs for chronic kidney disease?
    Katz IJ; Gerntholtz TE; van Deventer M; Schneider H; Naicker S
    Clin Nephrol; 2010 Nov; 74 Suppl 1():S113-8. PubMed ID: 20979975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sleep disorders occur very early in chronic kidney disease.
    De Santo RM; Bartiromo M; Cesare CM; Cirillo M
    J Nephrol; 2008; 21 Suppl 13():S59-65. PubMed ID: 18446734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Individuals with a family history of ESRD are a high-risk population for CKD: implications for targeted surveillance and intervention activities.
    McClellan WM; Satko SG; Gladstone E; Krisher JO; Narva AS; Freedman BI
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S100-6. PubMed ID: 19231753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.